Despite the long-recognised health benefits of exercise andphysical activity, purposeful integration of exercise training intostandard cancer treatment, extending through survivorship, hasbeen relatively restrained. However, significant advances havebeen made in the field of exercise oncology in the last two decades.Numerous clinical trials have demonstrated therapeutic benefits ofstructured exercise to enhance health and physiological function.1[2_TD$DIF]Moreover, habitual exercise has emerged as a central componentfor primary and secondary disease prevention in cancer survivors.While the latest exercise guidelines2 state that individuals should‘avoid inactivity’ and engage in ‘150 minutes of moderate-intensityexercise or 75 minutes of vigorous-intensity exercise per week’,given the notable heterogeneity among cancer survivors, optimalexercise prescription/progression varies.
展开▼
